Track NXL and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Nexalin Technology Inc.
1776 Yorktown, Houston, TX, United States, 77056
IPO
2022
Employees
8
Industry
Medical Devices
Sector
Healthcare
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
Insider Transactions
Quarterly buy vs. sell activity
Sell (left)Buy (right)
Q1 20250+5
5
Q4 20240+1
1
Q2 20240+2
2
3-quarter cumulative
0 sells8 buys
Analyst Ratings
1 analysts covering
Buy100%recommend buy
Buy
1
Hold
0
Sell
0